89bio Company
89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2018
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
4
Total Funding:
£27M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership